ResearchIn-Press PreviewCell biologyNephrology
Open Access | 10.1172/jci.insight.186290
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Márquez-Nogueras, K. in: PubMed | Google Scholar
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Knutila, R. in: PubMed | Google Scholar
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Vuchkovska, V. in: PubMed | Google Scholar
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Yang, C. in: PubMed | Google Scholar
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Outeda, P. in: PubMed | Google Scholar
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by
Wallace, D.
in:
PubMed
|
Google Scholar
|
1Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, United States of America
2Center for Proteomics and Molecular Therapeutics, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, United States of America
3Department of Medicine, University of Maryland School of Medicine, Baltimore, United States of America
4Department of Internal Medicine, University of Kansas Medical Center, Kansas City, United States of America
Find articles by Kuo, I. in: PubMed | Google Scholar
Published August 5, 2025 - More info
Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2, which encode polycystin-1 (PC1) and polycystin-2 (PC2) respectively. These proteins are thought to form a signaling complex that can flux cations including calcium. One of the earliest symptoms in ADPKD is a decline in the concentrating ability of the kidneys, occurring prior to cyst formation. We reasoned that hyperosmolality stimulates the polycystin complex, and that the loss of this function impairs water reabsorption. We found that hyperosmolality resulted in the phosphorylation of a microtubule associated protein 4 (MAP4) in a PC1-dependent manner which then elicited ER-localized PC2 calcium signals. ER-localized PC2 hyperosmotic calcium signals were required for trafficking of the water channel aquaporin (AQP2). Pre-cystic PC1-KO and PC2-KO murine kidneys had cytosolic localized AQP2, and diluted urine compared to their respective controls. Kidney tissue sections from ADPKD patients showed decreased AQP2 apical membrane localization in cystic and non-cystic tubules. Our study demonstrates that osmolality is a physiological stimulus of the polycystin complex, and loss of polycystin osmosensing results in impaired water reabsorption via AQP2. This likely contributes to the declined concentrating ability of the kidneys and high circulating vasopressin levels in ADPKD patients.